Board Member
GRI Bio, Inc. (GRI)Board Member
Arcturus Therapeutics Holdings Inc. (ARCT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2013-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2013-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $750,000 | $1,691,000 |
| 2024 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $695,000 | $3,697,000 |
| 2023 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $698,000 | $4,892,500 |
| 2022 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $630,000 | $5,594,000 |
| 2021 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $600,000 | $960,000 |
| 2020 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $500,000 | $12,861,500 |
| 2019 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $450,000 | $1,165,818 |
| 2018 | Arcturus Therapeutics Holdings Inc. (ARCT) | CEO | $425,000 | $2,687,044 |
Earnings-call appearances and filed executive appointments or departures, newest first.
